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OVERVIEW
Fibrin is ubiquitous in inflammatory disease processes and is thought to
be rapidly metabolized by a variety of fibrinolytic enzymes (e.g. plasmin)
producing, at the site of inflammation, a wide range of degradation products.
These products of fibrinogen metabolism (designated Fibrinogen Derived
Factors, or FDFs) have been shown to possess wide ranging biological
activities in vitro and in vivo.63 For example, FDFs have been shown to
affect coagulation, 5 vasopermeability,22 endothelial cell integrity,64,65
inflammatory cell chemotaxis,21 as well as lymphocyte proliferation and
antibody production.20 In light of the immunomodulatory effect that FDF’s
have on other inflammatory cells (e.g. lymphocytes), our laboratory has
hypothesized that FDFs also modulate neutrophil function in vitro and in vivo
(see Figure l). It was hypothesized that host and/or bacterial derived factors
present at a disease site generate specific FDFs which are capable of altering
the PMN (neutrophil) causing down regulation or suppression of neutrophil
function. For the purpose of this thesis, "down regulation" will refer to
suppressing neutrophil function and "up regulation" will refer to augmentation
of neutrophil function. The resulting "suppressed" neutro.hils may be
deficient in phagocytosis and killing of bacteria which may result in the
proliferation of bacteria at the diseased site. Fibrin deposition increases
from the resultant tissue damage, and the cycle repeats itself. With this
hypothesis in mind, the general objective of this study was to determine if
FDFs known to be produced locally in an inflammatory lesion can modulate
neutrophil function and host defense in vivo.
Since no systematic investigations to date have been undertaken to
study the effects of FDFs on neutrophil function, short term goals or" the
present studies were developed to evaluate the in vitro effects of F DFs on
key neutrophil functions involved in host defenses. Although there are a wide
number of neutrophil functions that contribute to host defense, the direct
microbicidal activity of the neutrophil is central to host defense. Thus,
initial experiments focused on determining the direct effect of FDF on
microbicidal activity. Preliminary data generated at the outset of this study
demonstrated the ability of FDF to significantly inhibit PMN microbicidal
activity.
PMN microbicidal activity may be divided into adherence dependent
phenomena, oxygen dependent microbicidal phenomena, and oxygen
independent microbicidal phenomena, and oxygen independent microbicidal
phenomena. Therefore in order to gain insight into the mechanism of FDF
inhibition of microbicidal activity, the effect of FDF on adherence,
phagocytosis (adherence dependent), H202, chemiluminescence (oxygen
dependent), and degranulation (oxygen independent) were studied.
The long term goal of this project is to determine the role of FDFs in
inflammation and host defense in general and in human periodontitis
specifically.
Periodontal disease is an excellent model for studying host-parasite
interactions in a chronic inflammatory lesion. Organisms capable of
producing fibrinolytic enzymes have been found in increased numbers in
periodontal disease.77 Fibrin has been found in diseased periodontal disease
tissues54 and in gingival fluid obtained from perodontis lesions. 30 Moreover,
FDF have not been detected in clinically normal tissues.30 Since neutrophils
have been shown to be essential in preventing the progression of
inflammatory periodontal disease, 48 it is hypothesized that the production of
F DF’s by bacteria inhibit neutrophil function in periodontal disease allowing
for disease progression. The identification of specific FDF’s will not only
provide insight into the mechanism involved in inhibition of neutrophil
function, but may provide a useful diagnostic tool in identifying local
inflammatory lesions in which connective tissue destruction is occurring.
Finally, it is hoped that i_n vitro findings can be extended to a relevant i_.n vivo
disease model.
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REVIEW OF THE LITERATURE
AND RATIONALE
Fibrin is a ubiquitous protein found in virtually all in inflammatory
processes, e.g. renal disease,21 transplant rejection phenomena, ll
disseminated intravascular coagulation,5 neoplasia,12 and inflammatory
periodontal disease30 to name but a few. Previously, fibrin was thought to
fu.nction primarily as a hemostatic plug, with past investigations dealing
primarily with the physical manifestations of fibrin deposition, e.g., fibrin’s
role in hemostasis, tissue repair and limiting the spread of microorganisms
from the disease site. Interestingly, relatively little work has been done
concerning the biological role of peptides derived from fibrinogen
metabolism. This is surprising in light of: l) interrelationships that have
been shown to exist between the coagulation system and inflammatory
processes,71 2) the high concentration of these peptides found in many
inflammatory lesions43 and 3) evidence establishing that these peptides do
have effects in vivo and i__n vitr.o. For example, during acute inflammatory
reactions in models of acute respiratory disease, 46 a reduction of pulmonary
edema has been seen following fibrinogen depletion. In chronic inflammation,
a role for fibrin has been suggested through the use of anticoagulants, e.g.
heparin has been shown to inhibit intraocular tuberculin hypersensitivity.79
This observation has been supported by other studies that demonstrate that
the anticoagulants ameliorate the effects of delayed type hypersensitivity
reactions. 13 In addition, the typical induration present in delayed type
hypersensitivity reactions is not seen in individuals with a rare
afibrinogenem ia. 15 Anticoagulants and genetic defects in fibrinogen
production were used in the studies cited above to limit fibrin accumulation
and FDF production, however, n an inflammatory reaction i_.n vivo FDF
production and their concentration is dependent upon the balance of protease
and anti-protease systems.
Thus a variety of FDFs may be obtained from thrombin, plasmin, or
cellular derived protease metabolism of fibrinogen. A brief review of the
general pathways of fibrinogen metabolism and the biological activities
associated with their metabolites is provided below.
Fibrin Metabolism
The formation of fibrin from its precursor fibrinogen is the result of a
complex system of regulatory zymogen enzymes which function as serine
proteases. These zymogen enzymes, or coagulation factors, have been
assigned Roman numerals I-XIV, and are divided functionally into two
pathways; the intrinsic pathway and the extrinsic pathway (see figure 2).
The instrinsic pathway and the extrinsic pathways are linked through their
conversion of Factor X which is the first key reaction leading to the
formation of a clot. The other two key reactions are: l) the formation of
thrombin and 2) the formation of fibrin. Clotting involves an interplay
between the two pathways and each is needed for proper clotting. The
intrinsic pathway is activated by exposure of instrinsic blood components
(Factor XII) to a negatively charged surface (subendothelial collagen,
phospholipids). The extrinsic pathway is activated when trauma to a blood
vessel releases a lipoprotein called Tissue Factor. A complex of Tissue
Factor and Factor VII then catalyze the activation of Factor X, which along
with Factor V and Platelet Factor 3 cleaves prothrombin to produce
thrombin. The enzyme thrombin is responsible for the generation of fibrin
from its precursor fibrinogen. Fibrinogen is comprised of 3 pairs of
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Figure 2" Fibrinogen Metabolism Which Produces
Fibrinogen Derived Factors
polypeptide chains designeated A, B B and .46 Thrombin cleaves four
arginine-glycine bonds in fibrinogen releasing four peptides: an "A" peptic]e
from each alpha chain, and a B peptide from each of the two B chains. These
peptides are referred to as fibrinopeptides, while fibrinogen devoid of these
peptides is referred to as fibrin monomer. Fibrin monomers aggregate end-
to-end and side-to-side and polymerize, being held together by hydrophobic
bonds, and this fibrin is referred to as soluble fibrin. At the time of
fibrinopeptide release, thrombin activates Factor XIII (i.e., fibrinoligase)
which replaces the hydrophobic bonds on the polymerized fibrin with covalent
bonds forming an insoluble fibrin polymer. The coagulation cascade, if
unregulated, could lead to excessive fibrin formation, pathologic thrombiosis,
and tissue damage. Fibrin(ogen) metabolism is regulated by a variety of
proteases and antiprotease which controls fibrin deposition and the
fibrinolysis.
Control of fibrin deposition is achieved by protease inhibitors such as
anti-thrombin Ill which blocks most of the serine proteases in the coagulation
cascade. Other minor inhibitors of the coagulation cascade include: anti
trypsin, c2 macroglobulin, and C l esterase inhibitor. If these inhibitors fail
to prevent excessive fibrin formation, then the fibrinolytic system plays a
major role in removing p})tentially harmful fibrin deposits from the
vasculature and/or tissues. Fibrinolysis can be considered to be the
physiologic counterpart to the process of fibrin deposition. Its function,
along with the inhibitors mentioned above, is to limit the accumulation of
fibrin. The major enzyme responsible for fibrinolysis is plasmin and it exists
in plasma as its precursor plasminogen. Plasminogen is present in serum as a
single polypeptide chain with a molecular weight of 90,000. The principal
site of plasminogen synthesis is the liver although some controversy exists
concerning other sources 18. Plasminogen is converted to plasmin through the
enzymatic cleavage of two peptide bonds liberating two peptide chains; a
light chain and a heavy chain; the active site of plasmin is located on the
light chain. Numerous activators of plasminogen exist and the most
important physiologic pathways for plasminogen activation are the Hageman
factor pathway and endothelial synthesis of plasminogen activator. The
Hageman factor pathway functions through the interaction of factor XIIa
with a plasminogen proactivator. This interaction leads to production of an
activator that converts plasminogen to plasmin which then degrades fibrin.
Tissue plasminogen activator (t-PA), secreted by a variety of cells including
maerophages nd vascular endothelial cells, is a single polypeptide chain with
a molecular weight of 70 kDa. The rate of plasminogen activation by t-PA
increases several hundred fold by the presence of fibrin suggesting the
formation of a t-PA-fibrin complex. Plasmin has wide ranging enzymatic
activity and has an equal affinity for fibrin and fibrinogen. Due to its wide
ranging enzymatic activity, plasmin is capable of degrading coagulation
factors and activating complement. The degradation of coagulation factors
can lead to hemorrhage, and the activation of complement has multiple
effects such as increased vascular permeability and red blood cell hemolysis.
Since plasmin has multiple biological activities and its precursor is
found in most biologic fluids,6 regulation of plasmin activity must occur.
Inhibitors of plasmin activity include alpha2-antiplasmin alpha2-
macroglobulin and Cl esterase inhibitor. The lysis of fibrin and fibrinogen by
plasmin proceeds by cleavage of the corboxy terminal of the A a chain. The
process continues with destruction of the B chain and finally the chain is
i0
degraded. 18 This process of enzymatic dgestion results in the production of
four clinically recognized FDFs, the X, Y, D and E fragments, in order of
production as well as low molecular weight peptides. The low molecular
weight peptides are not well defined as to their structure, however they have
been shown to possess biologic activity.20
The degradation of fibrin and fibrinogen can occur by the action of
enzymes other than plasmin. For example, inflammatory cells such as
neutrophils and macrophages are capable of degrading fibrin, producing FDFs.
Neutrophil derived elastase cleaves fibrin, producing peptides different from
those produced by plasmin. Thus fibrinogen can be metabolized by a wide
variety of cell-derived proteases producing numerous large and small peptides
that have been shown to possess biologic activities.
B.,iological Ef.feets of FDF
Fibrinogen derived factors have been shown in the literature to have a
variety of biological effects i_.n vivo and i_n vitro. Provided below is a brief
review of the effects of FDF on l) coagulation, 2) vasopermeability and 3)
leukocyte/lymphocyte function. Information pertaining to microbicidal
degradation of fibrinogen and its possible relationship to periodontal disease
is also provided.
This review is not only provided for the purpose of a general
background, but to provide the foundation for the hypothesis of the role of
FDF in regulating PMN function. For example, information pertaining to the
effect of FDF on cells and factors involved in coagulation and
vasopermeability was included due to the importance of these processes in
inflammation and host defense. Background information is provided on the
ability of bacteria to degrade fibrinogen producing FDF was cited to suggest
Ii
a link between bacterial derived FDF and modulation of host defense.
Finally, evidence pertaining to FDF and periodontal disease was included to
show how these factors may affect an inflammatory disease of bacterial
origin.
,FDF and Coagulatio,n
Inhibition of coagulation is important in diseases where fibrinolysis
predominates, e.g., carcinomas, and disseminated intravascular coagulation.
In the case of disseminated intravascular coagulation (DIC), the presence of
FDF’s determines the clinical signs and symptoms of this condition. In DIC,
if fibrinolysis is dominant, hemorrhage occurs.5 FDF’s have profound effects
on the coagulation system and have been shown to be anti-coagulants i_.n
vivo.6 These studies demonstrated that FDFs directly inhibited coagulation
by l) interfering with fibrin monomer polymerization and 2) inducing a defect
in platele t function.
.F.. DF and.Vasopermeability
In addition to their effects on coagulation, FDF’s have direct effects on
the vasculature. FDF’s have been shown to ncrease vascular
ermeability3,63,64 and induce isolated arterial contraction.7 A series of
studies have described the isolation and characterization of peptides which
have vasopermeability effect in vivo. These peptides have been identified as
Aa 224-324 from the middle region of the A a chain and B 43-47.26,3,4
In a series of reports, Kreutzer and colleagues have shown that FDF’s
related to BI-42 can induce vascular endothelial cell injury i_.n vitro.63,64,65
Moreover, these F DF’s were shown to injure vascular endothelial cells in
aorta organ cultures, 17 and to induce vasopermeability in skin.41 These
findings are significant when one considers the role of the vasculature in
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inflammatory reactions. Endothelial cells are intimately involved with the
regulation of vascular permeability. An increase in vasopermeability is one
of the first signs of inflammation allowing for the exchange of inflammatory
cells from the vasculature to a tissue site. This increase in vasopermeability
is followed by recruitment of cells to the site of inflammation. Since fibrin
is present at high concentrations at many inflammatory sites, its effect on
inflammation or inflammatory cells may be significant.
Effect of FDF On .Leukocyte/Lymphocyte Fun.ction
As mentioned above, recruitment of inflammatory cells to the site of
inflammation is necessary for the process of inflammation to occur. FDF’s
have been shown to affect leukocyte/lymphocyte function. For example,
FDF’s (BB 30-43) have been shown to induce neutrophil chemotaxis in skin.
Leukocyte accumulation at two hours was significantly greater with injection
of F DF’s than with injection of leukotriene B4.68 The above report suggests
that peptides that are cleaved early n the formation of a fibrin clot (B 30-
43) enhance chemotaxis of neutrophils. Girmann et al. first suggested that
FDF derived from the plasmic cleavage of fibrinogen suppress the immune
esponse in vivo, and inhibit the response of blood mononuclear cells to
phytohern aglutinin.27 This work has been extended by Saldeen and
Edgington,27, 20 who found hat FDF’s inhibit the proliferative response of
lymphocytes to mitogens and to allogeneic cell stimulation. Inhibition was
dose specific and could be elicited before, at the time of, or as late as 4
hours after mitogen stimulation.
I_.n vivo experiments have demonstrated that low molecular weight FDF
can suppress cell mediated immune reactivity61 and are associated with
enhancement of tumor growth in BALB/c mice62. Recently, receptor
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mediated binding of large molecular weight FDFs to macrophages has been
described59. The binding of FDFs to microphages has also been shown to
increase production of the monokine Hepatocyte Stimulating Factor.51
Therefore, the binding of FDF to macrophages may represent a feedback
regulatory mechanism by which fibrinogen synthesis is regulated.
Fibrinogen Metaboli.sm and Mcrob...e.s
The effect of FDF’s on leukocyte/lymphocyte function is diverse, i.e.
chemotaxis and lymphocyte responses to mitogens. Clearly, the body of
literature to date supports the role of FDF’s as modulators of local
inflammatory reactions. If FDF’s function as local modulators of
inflammation, it is not unreasonable to hypothesize that bacteria have
developed ways of using the regulatory effects of FDF’s to their advantage.
Classically fibrin has been thought to wall-off an inflammatory lesion
and act as a barrier to the spread of microorganisms contained in the
lesion. 63 IIowever, very little work has examined the identity of FDF
produced by bacterial enzymes and the effects of these products on host
inflammatory cells. This is surprising in light of l) the growing body of
literature demonstrating that FDF’s have effects on inflammatory cells, and
2) the ability of many pathogens to synthesize extracellular factors that
produce FDF’s. Streptokinase, produced by B hemolytic streptococci, is the
most widely known factor responsible for FDF production. Streptokinase is a
single chain protein of molecular weight 47,000.9 Streptokinase functions by
forming a complex with plasminogen and thereby inducing a conformational
change. This conformational change exposes an active enzymatic site within
the complex which may cleave an arginal-valine bond in other plasminogen
molecules forming plasmin.9 Other bacteria (in addition to B hemolytic Strep)
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produce fibrino(geno)lytic enzymes. Oral bacteria such as Bacteroides 0ralis
produce a streptokinase-like .molecule which acts indirectly by activating
plasminogen.53 Bacte.iodes gingivalis (an organism associated with
periodontitis disease sites) possesses a membrane-bound protease which
causes fibrinolysis.53 Treponema dentic0!a produces an enzyme which acts
directly on fibrin to effect lysis.53 In a recent study, a correlation was found
between possession of fibrino(gene)lytic activity and the presence of
microorganisms in inflammatory disease sites. Bacteria were isolated from
deep periodontal pockets and the predominating strains isolated were tested
for fibrino(geno)lytic activity. Fusobacterium, Bacteroides and Actinomyces
species all exibited fibrino(geno)lytic activity.77 These organisms are found
in increasing numbers in adult periodontitis.69 These findings suggest that
fibrino(geno)lytic enzymes produced by bacteria may function as virulence
factors. However, to discuss a possible role for bacterial factors related to
fibrinogen metabolism in the progression of chronic disease processes an
experimental model must be selected, periodontal disease represents such a
model.
Fibrinogen Metabolism and Periodontal Disease
Periodontal disease is an excellent prototypical model for studying and
illustrating host-parasite-fibrinogen metabolism interrelationships. It is
ideally suited becaus the lesions and disease activity are localized (fibrin
exerts its modulating effects locally), the lesions are easily accessible, and
documented animal models exist.55 Regardless of these advantages and the
almost universal presence of fibrin in inflammatory lesions, little work has
been done to examine FDF’s role in periodontal disease. Provided belov is a
15
brief review of what is known about FDF’s and host-parasite relationships in
periodontal dsease.
Bacteria, which are suspected periodontal pathogens, have been shown
to possess the ability to degrade fibrin (as dscussed above). Fibrin has been
shown to be present in periodontal pockets, and has been seen lining the
pocket wall in close proximity to emigrating neutrophils.54 In related
studies, neutrophil enzymes have been shown to be capable of degrading
fibrinogen.28 A limited number of studies have looked at the capability of
epithelial cells lining the periodontal pockets to cause fibrinolysis. These
cells lining the pocket have been shown to secrete plasminogen activators and
cause fibrinolysis in humans and a number of animals.70,45 Plasminogen
activator synthesis has been reported to be a function of cell keratinization
and cell turnover.70 Epithelial cell production of plasminogen activators may
be of significance in the pathogenesis of periodontal disease due to l)
plasmin’s ability to activate complement, and 2) fibrinolysis produces FDF’s.
One study has looked at the presence of FDF’s in the gingival fluid of healthy
patients and those with periodontitis. 30 FDF’s were found in 12 of 14
patients with periodontitis. FDF’s were not found in patients who were
clinically healthy.30 Therefore, the necessary enzymes (bacterial, neutrophil
or tissue) and substrates [fibrin(ogen)] are present in periodontal pockets for
the production of FDF’s.
It is possible that the association between FDF’s and periodontal disease
may be due to effects that FDF’s have on neutrophil function. To date, no
studies have investigated the effects of FDF’s on neutrophil microbicidal
functions. Neutrophils are present in the gingival sulcus, and existing
evidence suggests that they play a protective role.48 Evidence to support
16
this role is based on peridontal disease severity in patients afflicted with
neutrophil abnormalities such Chediak-}ligashi syndrome and neutropenic
states.29,14 Patients with defects in neutrophil function, or possessing
decreased numbers of neutrophi]s exhibit early severe periodontal destruction
and loss of teeth. 14 In addition, it has been reported that the phagocytic
activity of neutrophils in severe periodontal lesions is diminished locally.49
Therefore FDFs have been shown to be associated with a disease process in
which the local control of neutrophil function is of primary importance.
HYPOTHESIS AND SPECIFIC AIMS
As was presented in the previous section, FDF have been shown to be
associated with a wide range of disease processes in which host defense is of
primary importance. Previous investigations of the effects of F DF on
immunologic cell function have focused on the lymphocyte. 18 Since the
neutrophil plays an important role in host defense, the present study was
undertaken to determine the effect of FDF on PMN function in vitro.
In light of the fact that FDF have been shown to affect lymphocyte
function n yitro and i__n vi_y.vo 18,61 the following general hypothesis was
developed: that local generation of FDF by either tissue or microbe derived
proteases can result in the down regulation of neutrophil function i.e.
suppression. This down regulation of neutrophil function result in depressed
host defense with resulting proliferation of bacteria at a disease site. This
increase in bacterial proliferation results in increased tissue damage, fibrin
deposition and the cycle repeats itself.
To begin to test this hypothesis, the effect of FDF on P MN microbicidal
activity was studied. Preliminary data were developed at the outset of this
study which demonstrated the ability of low molecular weight peptides (FDF)
derived from the plasmin digestion of fibrinogen to inhibit PMN phagocytosis
and killing of bacteria. Therefore to dissect the molecular/cellular basis of
FDF activity, specific aims were developed to systematically study the
effect of FDF on those functions involved in microbicidal activity. Functions
involved in PMN microbicidal activity can be divided into adherence
dependent functions (binding of a microbe to the P MN, phagocytosis) oxygen
dependent functions (H202 production) and oxygen independent functions
(degranulation). The effect of FDF on chemotaxis was studied because this
17
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function is directly related to host defense and microbicidal activity. Those
specific aims are as follows"
Specific Aims
SPECIFIC AIM l: To determine the effect of FDF on neutrophil
functions involved in host defense.
Question 1: What is the Effect of FDF on PMN chemotaxis?
Study l: Effect of FDF on chemotaxis
Study 2: Are FDF effects reversible
Question 2: What is the effect of FDF on Fc receptor function and
phagocytosis?
Study 3: Microscopic quantification of adherent opsonized
sheep red blood cells
Study 4: Microscopic quantification of phagocytosed sheep red
blood cells
Question 3: What are the effects of FDF on oxygen dependent
microbicidal activity of leukocytes?
Study 5: Chem ilum inescence
Study 6: H202 production
Question 4: What are the effects of FDF on leukocyte
degranulation?
Study 7: Release of granule components extracellularly
Quantification of lysozyme
Study 8: Primary vs. secondary granules
a. B glucuronidase quantification as a primary
granule marker
b. Lactoferrin quantification as a secondary
granule marker
SPECIFIC AIM 3: To characterize the identity of FDF involved in the
suppression of leukocyte function.
Study 9: Antibody blocking of FDF activity
Study 10: Protease sensitivity of FDF
Study l l: Separation of FDF according to molecular weight and
subsequent testing in a screening assay.
a. Separation of FDF according to molecular
weight using Amicon Itrafiltration
b. Testing of molecular weight functions using
neutrophil H202 production as a screening assa.v.
SPECIFIC AIM 4: To determine the effect of FDF on cell surface
adhesion molecules.
ao Effect of FDF on LFA-I expression
bo Effect of FDF on M O-I expression
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METHODS
Isolation and Purification of Fibrinogen
The method used to isolate and purify fibrinogen from plasma was a
modification of that employed by Doolittle, et al.19 (see Figure 3). Fresh
plasma was obtained (Red Cross, Farmington, CT) and fraction I
(corresponding to commerc|al preparations) was precipitated by the addition
of 0.22 volumes of cold 50% ethanol in 0.55 M trisodium citrate pH 7.1 while
lowering the temperature to-3C. After centrifugation, the precipitate was
washed with 0.5 original volumes of 7% ethanol pH 6.5 at-3%. The
precipitate was then dissolved in 15 mM phosphate buffer and the pH and
ionic strength were adjusted to 7.8 and 6.9 m.mho respect}vely. The
solubilized fibrinogen was then passed through a DEAE ion exchange
chromatography disk (AMF, Cuno, Meriden, CT) which has been demonstrated
to remove complement component C3 from plasma (Kreutzer unpublished).
After ion exchange chromatography, the fibrinogen was placed on a gelatin
sepharose column to remove fibronectin contamination. The void volume was
collected and cooled to 0C and "cold insoluble material" removed by the
addition of cold 20% ethanol to a final concentration of 2%. Centrifugation
removes a mucous like precipitate. Addition of more 20% ethanol to a final
concentration of 8% results in the precipitation of fibrinogen used in this
study.
Assessment of Fibrinogen Purity
Fibrinogen preparations were assayed for contaminants using: l) ELISA
to measure C3, C5 contaminations; 2) SDS-PAGE; 3) SDS-PAGE reduced
fibrinogen for fibronectin contamination; and total amino acid analysis.
21
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Plasma or Fraction I Fibrinogen
Precipitation with .22 volumes of cold
5 0% ethanol -3
and collect pelletcentrifuge
Wash with .5 original volumes
7% ethanol pH 6.5 -3
centrifuge and collect pellet
Dissolve in 15 mM phosphate
buffer pH 7.8; ionic strength 6.9 mmho
DEAE ion exchange
Removal of C3
Gelatin pharose
Removal of fibronectin
Addition of cold 20% ethanol to
a final concentration of 2%
Addition of 20% ethanol to a
final concentration of 8%
Precipitation of ibrinogen used in
experiments
Figure 3- Protocol for Fibrinogen Purification
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Preparation of FDFs
Purified fibrinogen was dissolved in 0.02 M Tris-HCl 0.1 M NaCl pH 7.8
to a final concentration of 4 mg/ml and warmed to 37. Plasmin (Sigma, St.
Louis, M O) (0.02 u/ml) was added to the fibrinogen and the mixture was
incubated for 18 hours stirring at 37C. Aliquots were saved at l rain, 15
min, l hour, 5 hours, 18 hours, and frozen at-80 for analysis using SDS-
PAGE. Following the 18 hour incubation, the large molecular weight
fibrinogen was separated from the plasmin generated peptides using an
amicon ultrafiltration unit. The unit contained a membrane which excludes
proteins > 30,000 M.W. The plasmin generated peptides 30,000 M.W. were
lyophylized and stored at-20C for use in the experiments.
Reeonstitution and, Standardizatign,,Of FDF, Pe[tid,es
The lyophilized peptides were reconstituted by the addition of disti.lled
water (see Figure 4). Peptide concentration was determined by absorbance at
212 nm, since standard protein assays are unable to quantify small peptides
accurately (212 nm is the region where peptide bonds absorb u.v. light). A
buffer of 0.02 M tris; 0.1 M NaCl, pH 7.8 was used to blank the instrument.
The peptide samples were adjusted to an abosrbance of 30, 15, and 7.5
absorbance units for use in experiments. Addition of 0.2 ml of 30:15 and 7.5
absorbance units to a 0.5 ml PMN solution resulted in a final concentration of
8.6, 4.3, and 2.15 absorbance units respectively. A 0.2 ml aliquot of a 30
absorbance unit solution was found to contain 260 pg/ml of FDF upon amino
acid analysis and corresponded to a starting solution of 6 mg/ml of
fibrinogen. These concentrations are biologically relevant.
PURIFIED FIBRINOGEN
-complement removed
-fibronectin removed
18 HOUR PLASMN DIGEST
AMICON FILTRATION
PEPTIDES < 30,000 MW
LYOPHILIZATION
RECONSTITUTION OF
PEPTIDES USED IN EXPERIMENTS
STANDARDIZATION OF
PEPTIDE CONCENTRATION
USING ABSORBANCE AT 212 nm
Figure 4: PROTOCOL FOR THE PRODUCTION OF LOW MOLECULAR
WEIGHT F DF
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Preparation of Control Small Molecular Weight Peptides
Small molecular weight peptides derived from BSA were prepared to
rule out any non specific effect small peptid.es might have on neutrophil
function. To prepare these peptides BSA was dissolved in 0.02 M Tris- HCI,
0.I M NaCI, pH 7.8 to a final concentration of 4 mg/ml. Small molecular
weight BSA derived peptides were produced using plasmin and methods
identical to that employed for generation of fibrinogen derived peptides.
Isolation of Polym.orphonuelear Leukoeyte from Whole Human Blood
Human PMN were isolated from citrated venous blood of healthy donors
(l ml 3.8% sodium citrate-dihydrate in 0.85% NaCl per 9 ml blood)using
Ficoll-Hypaque gradient centrifugation followed by dextran sedimentation
according to a modified method of Boyum.20 Briefly, a Ficoll-Hypaque
Solution was prepared by mixing 35.25 ml of Ficoll (9% wt/vol) with 10.00 ml
of Hypaque (50%) and 4.75 ml of distilled H20. Then 25 ml of diluted blood
(l part whole blood to l part 0.85% NaCl)was layered over 13 ml Ficoll-
Hypaque solution in a 50 ml polypropylene test tube and centrifuged at 500g
at room temperature for 30 minutes. After centrifugation, the blood cells
were separated into two fractions, an upper layer corresponding to the
mononuclear cell layer at the interface region between the plasma and the
Ficoll-Hypaque solution, and a cell pellet which contained erythrocytes and
granulocytes. After the removal of the mononuclear cell layer, plasma and
the Ficoll-Hypaque Solution, PMN were separated from erythrocytes by
adding 30 mls of 3% Dextran (in 0.85% NaCl), mixing and incubating at room
temperature for 45 minutes. The supernatant which contained the PMN was
removed and centrifuged at 500g for 10 minutes at 4C. To eliminate the
contaminating red blood cells: The resulting pellet was resuspended with red
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blood cell lysing solution (0.15 M NH4CI; 0.01M KHCO3; 0.001M EDTA: pH
7.2) followed by 3 washes with HBSS. The PMNs were adjusted to the
appropriate concentration with HBSS for use in experimental studies. The
PMN preparations contained 82 to 95% neutrophils as determined by
cytocentrifugation and Wright-Giemsa staining. Greater than 98% viability
of isolated cells was obtained as determined by trypan blue dye exclusion.
Determin,ation of Effeet,,of FDFs on.PMN Viability
Preliminary data demonstrated that FDFs inhibited PMN phagocytosis
and killing of bacteria. However it was not known whether the FDFs or
contaminants in the FDF preparation were toxic to the neutrophils. Trypan
blue dye exclusion is typically used to detemine cellular viability, but it is not
a very sensitive technique. A very sensitive technique for measuring cellular
viability is the measurement of lactate dehydrogenase (LDH).80 LDH is a
cytosolic enzyme, therefore detection of LDH in the extracellular fluid is an
indication of cell death or loss of membrane integrity. The assay is based on
the spectrophotometric measurement of NADH consumption during the LDH
c.atalyzed reduction of pyruvate to lactate.
Pyruvate + NADH _LD.H, Lactate + NAD + H+
The protocol for treatment of the PMNs with FDFs was identical to
that used in all functional assays. FDFs from three different preparations
were used. 0.2 mlofFDFat 30 O D, 15 O D, 7. 5 OD were added to 0 .5 mlof l
x 107 PMN/ml. For the I00% LDH content (positive control) cells were lysed
with 0.1% Triton X. Buffer was added to the negative (sham) controls. The
cells were then incubated in a shaking waterbath for 20 minutes at 37C.
The PMNs were centrifuged down at 400xg for l0 minutes and the
supernatants collected. For the LDH assay 50pl of neutrophil supernatant
substrate was added to 1.0 ml N ADH substrate 0.14 mg/ml. 50 II of Na
pyruvate (Sigma 490-I) was added to start the reaction, and the absorbance
at 340nm was determined.
Effects of FDF on PMN Morphology
a. Adherence to Plastic
To determine the effects of FDFs on plastic adherence eutroohils (0.5
ml of 5xl06 PMN/ml) were incubated with 0.2 ml of FDF at 30, 15 and 7.5
OD unit concentrations (for a final concentration of 8.6, 4.3 and 2.15 OD) for
20 minutes at 37C. Following the incubation l set of samples was added to
a 6 well tissue culture plate (Falcon) and incubated for 30 minutes. An
identical set of samples was washed 2x with 2.5 ml of HBSS followed by
addition to the 6 well plate and incubated for 30 minutes. Photos of the cells
were taken using light microscopy 10x.
b. Transmiss!on and Scanning Ele.ctron M icroso.py
To determine the effects of FDFs on neutrophil ultrastructure
neutrophils (0.5 ml of Ixl07 PMN/ml) were incubated with 0.2 ml FDF (final
cpncentration 8.60D) for 20 minutes at 37C shaking in a water bath.
Following the incubation, the cells were placed on ice and submitted in
suspension for scanning and tra.nsmission electron microscopy.
Effect of FDF on PMN Chemotaxis
The effect of FDF on PMN chemotaxis was determined using a standard
multiwell Boyden chamber assay with 8 lm nitrocellulose filters (Millipore
Bedford MA). For these studies PMN were isolated from peripheral blood as
previously described and adjusted to 5 x 106/ml. The cells (0.5 ml of 5 x 106
PMN/ml) were added to 0.2 ml of FDF at 30. 15 and 7.5 O.D. unit
concentrations for a final cocentration of 8.6, 4.3 and 2.15 O.D. and
incubated for 20 minutes at 37C shaking in a waterbath. HBSS was added to
control PMN. An aliquot (0.250 ml) of each sample was added to the top
chamber of the plate and 4% activated serum was used as a chemoattractant
and added to the bottom compartment. All samples were assayed in
triplicate. The multiwell plates were incubated for 45 minutes in a moist
CO2 chamber followed by staining of the filters. Chemotaxis ,as quantified
using an Olympus microscope coupled to an Optomax image analyzer. Three
high power fields were counted for each fIter resulting in 9 fields for each
sample. Chemotactic indices were determined, and % inhibition of
chemotaxis expressed as
mean experimental chemotactic index 1 x 100%
mean control’ chem0tatic index
Reversibility of FDF Induced Suppression of PMN Chemotaxis
FDF treated neutrophils and controls were washed to determine if the
effect of FDF on PMN chemotaxis was reversible. FDF treated samples and
c.ontrols were washed 2x with 2.5 ml of HBSS followed by centrifugaton (500
x g) for 8 minutes. After the second wash, the PMN were brought up to l ml
in 0.5% BSA/HBSS. The cells were then assayed for chemotaxis.
Adherence (Rosetting)
Adherence of an organism to the neutrophil membrane is an essential
step for its subsequent phagocytosis. Adherence is mediated by antibody, the
complement component C3b, and their receptors. The use of opsonized sheep
red blood cells in quantifying binding can provide a means of measuring Fc
receptor function due to the presence of specific anti-sheep red blood cell
antibody on the RBC surface. Adherence or rosetting of SRBC was
quantified microscopically to assess Fc receptor function on the neutrophil.
For these studies PMNs were isolated from venous blood as described and
adjusted to 5 x 106 cells/ml. FDF aliquots (0.2 ml of O.D. 30, 15, and 7.5)
were added to 0.5 ml of cells and incubated for 20 minutes. The volume was
then brought to l ml by the addition of 0.3 ml HBSS. The l ml samples were
then split into two 0.5 ml samples and 0.5 ml of sheep red blood cells
opsonized with rabbit anti-sheep IgG were added (2.5 x 106; PNM/RBC ratio
l:l) to the PMN. The samples were placed on a rotating tube rack for 30
minutes at 37. After incubation the samples were placed on ice for 15
minutes to arrest phagocytosis followed by centrifugation at 300g for 15
minutes at 4 C. Extracellular !IBC were not lysed. At this point the
samples were centrifuged and the resulting pellet washed twice with HBSS.
After the final washing the pellet was resuspended with l ml of HBSS
containing 0.1% BSA. For each reaction sample duplicate smears were
prepared by using cytocentrifuge (500 r.p.m, for 5 minutes) followed by
Wrights-Giemsa staining. The smears were examined using light microscopy
(l.00x) and the number of adherent red blood cells per PMN in a total of 200
PMN were counted. PMN that appeared to be within the PMN were counted
as adherent.
Erythrophagoeytosis
Binding of a microorganism to a PMN and its subsequent phagocytosis
are the first steps involved in the microbicidal process. Therefore, it might
be a potentially important step where FDF regulates microbicidal activity
e.g., FDF down regulation. The effect of FDF on neutrophil binding and
phagoeytosis was assayed using the erythyrophagocytosis assay. Many
phagocytosis assays have inherent problems in that they are unable to
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differentiate between adherent and ingested particles. Phagocytosis assays
using antibody coated SRBC eliminate this problem because extracellular
RBC can be lysed and eliminated (using NH4CI lysis) leaving intracellular
RBCs intact. For these studies PMNs were isolated from venous blood as
described and adjusted to 5 x 106 cells/ml. FDF aliquots (0.2 ml of O.D. 30,
15: and 7.5) were added to 0.5 ml of PMN and incubated for 20 minutes. The
volume was then brought to l ml by the addition of 0.3 ml HBSS. The l ml
samples were then split into two 0.5 ml samples and 0.5 ml of sheep red blood
cells opsonized with rabbit anti-sheep IgG were added (2.5 x I07; PMN/RBC
ratio l:10) to the PMN. The samples were placed on a rotating tube rack for
30 minutes at 37. After incubation the samples were placed on ice for 15
minutes to arrest phagocytosis followed by centrifugation at 300xg for 15
minutes at 4C. The cell pellet was then resuspended in 2 mls of cold red
blood cell lysing solution (0.5 M NH4CI, 0.01M KHCO3, 0.001 M EDTA, pH
7.2) to eliminate adherent RBC. At this point the samples were centrifuged
at 300g for 15 minutes at 4 C and the resulting pellet washed twice with
HBSS. After the final washing the pellet was resuspended with l ml of HBSS
containing 0.1% BSA. For each reaction sample duplicate smears were
prepared by using a cytocentrifuge (500 r.p.m, for 5 minutes) followed by
Wrights-Giemsa staining. The smears were examined using light microscopy
(100x) and the number of intracellular red blood cells per PMN in a total of
200 PMN were counted.
Chemilumineseenee ,,Assay.
Adherence of a particle to the neutrophil membrane is associated with
an increase in oxidative metabolism known as the "respiratory burst." This
event is associated with the production of various chemical species important
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in oxygen dependent microbicidal activity such as hydrogen peroxide,
superoxide anion and singlet oxygen.lO Singlet oxygen is formed by the
reaction of the H202 and hypochlorite which involves the action of the
myeloperoxidase-halide system. The formation of singlet oxygen is followed
by the emission of light known as chemiluminescence. Chemiluminescence
was measured to determine the effect of FDF on PMN oxidative metabolism.
Sensitivity was increased by using the cyclic hydrazide luminal .which acts as
a substrate for singlet oxygen. The assay can be performed on resting or
stimulated cells since baseline PMN metabolic activity causes chemilumi-
nescence. Resting chemiluminescence was performed to determine the
effect of FDF on PMN devoid of any challenge.
For this assay a 5.5 mM stock solution of luminol in DMSO was prepared
and diluted 1.200 prior to use in HBSS. 3.9 ml of HBSS, 0.2 ml of luminol
(final concentration 1.0 lM), 4 ml opsonized zymosan (1.25 mg/ml) were
added to 10 ml scintillation vials and placed in a B counter shifted to l
photomultiplier tube (3H channel). The vials were dark-adapted for 20
minutes. Prior to the experiment, 0.5 ml of PMN (5 x 104/ml) were incubated
with 0.2 ml of FDF (for a final concentration of 8.6, 4.3, and 2.15 OD units)
for 20 minutes. The cells were brought to a volume of l ml and dded
sequentially to the scintillation vials every minute. Values reported are those
for the peak response which routinely occurred after 9 minutes of incubation.
PMN Ho2 Assay
Formation and release of the H202 is dependent upon phagocytosis and
can be used to indirectly quantitate this phenomena. Stimulated PMNs
produce a respiratory burst in which oxygen is reduced to superoxide which
then dismutates to form H202.
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202 +NADPH202 NADP++H+
202 + 211+ =-.H202 + O2
H202 produced during the respiratory burst can be quantitated because
H202 freely diffuses from the ceil. In the following experiments H202 was
quantitated using an assay which makes use of a color change that
accompanies the oxidation of phenol red.56 Horseradish peroxidase (HRP)
uses H202 and phenal red as substrates, and in an excess of HRP, the color
change of phenol red is proportional to the H202 concentration.
PMNs isolated from venous blood were adjusted to a concentration of 2
x I07 PMNs/ml. FDF aliquots (0.2 ml) at various concentrations 30 OD, 15
OD and 7.5 were added to 0.5 ml cells for a final FDF concentration of 8.6
4.3 and 2.15 respectively. Buffer was added to controls. The FDF cell
mixture was incubated for 20 minutes in a shaking water bath at 37. The
final cell volume was brought to 1.0 ml and 10 l of phenol red 20 raM, 10
HRP (14 mg/ml), and various stimuli (10-6 M. FMLP, 10-7 M. PMA 10:l
zymosan) were added to the PMNs followed by incubation for l hour on a
rotating tube rack. NaOH (10 pl, 10 N) was added to stop the reaction. The
cells were spun down and the absorbance of the supernatant was determined
at 610 nm. A standard curve was obtained using 30% H202. The
concentration of H202 for the standard curve was determined using the
molar extinction coefficient for H202 (81 moles/cm-l at 230 nm).
Phagoeytosis Induced Lysozomal ,Enzyme Relea,e
To determine the effect of FDFs on phagocytosis neutrophils were
isolated from peripheral blood and adjusted to 2 x 107 cells/ml. PMN (0.5 ml)
were added to FDF at 30, 15 and 7.50.D. units for a final concentration of
8.6, 4.3 and 2.15 O.D. units and incubated as previously described. Enzyme
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release was stimulated by the addition of 0.3 ml of opsonized zymosan (3.3 x
108/ml) for a final PMN/zymosan concentration of l:10. The cells were
incubated for 45 minutes at 37C on a rotating tube rack followed by
centrifugation (500 g 8 minutes) and removal of the supernatant. 3 different
neutrophil supernatants were analyzed for lactoferrin, glucuronidase, and
lysozyme content.
Effect of FDF,on Degranulatio,n.
Degranulation of lysomal granules is an important step in neutrophil
function. These lysomal granules contain a variety of antimicrobial agents
important in the microbiocidal activity of the neutrophil. In addition to their
antimicrobial properties, (e.g. lysozyme, lactoferrin), certain intracellular
granule constituents can act as primary (azurophil) or secondary (specific)
granule markers.24 The effect of FDF on primary granule release was
determined by quantification of 8 glucuronidase which is a marker for that
granule. Secondary g.anule release was quantified by measuring lactoferrin
(a marker for secondary granules). Lysozyme release was quantified since it
is found in both primary and secondary granules. Provided below are the
methods used to quantify these enzymes.
B Glucuronidase
The B glucuronidase assay is dependent on the enzymatic conversion of
the chromogenic substrate phenolphthalein glucuronic acid to phenolphthalein
and glucuronate: 24
phenolphthalein glucuronic acid + H20 B glucuronase phenolphthalein +
glucuronate
The pH of the sample is changed by the addition of glycine buffer, causing a
shift in color due to the phenolphthalein. The change in absorbance is
directly proportional to the glucuronidase concentration.
Neutrophil supernatant (0.1 ml) from the experimental and control
samples was added to 0.7 ml of sodium acetate buffer (pH 4.5) and 0.2 ml of
0.01 M phenolphthalein glucuronic acid (Sigma). A standard curve was
established using phenolphthalein (Sigma) concentrations fro 2 to 200 lg/ml
(0.7 ml sodium acetate buffer, 0.1 ml standards, 0.2 ml 0.85% NaCI). The
standards and unknowns were allowed to incubate for 18 hours at 37C
followed by the addition of 1.0 ml .4 M glycine buffer (pH 10.5). Absorbance
of unknowns and standards was determined at 540nm. glucuronidase
concentrations were determined from the standard curve.
Lactoferrin Assay
Lactoferrin was quantified using an enzyme linked immunoabsorbant
assay. A 96 well microtiter plate was coated with 0.1 ml of 10 pg/ml IgG
rabbit antihuman lactoferrin (Cappel, Malvern, PA) in carbonate buffer pH
9.. The plate was incubated overnight at 4’C followed by washing 3 times
with PBS/tween. Neutrophil supernatant (0.1 ml) or lactoferrin standard
(Calbiochem, San Diego, CA) 1-64 ng/ml, (dissolved in I% BSA/PBS) was
added to the plate and incubated for 90 minutes at 37C. The plate was
washed 3 times followed by the addition of 0.1 ml of peroxidase conjugated
antilactoferrin (Cappel, Malvern, PA) 1:400 dissolved in I% BSA/PBS. The
plate was incubated for 90 minutes and washed 3 times. 0.1 ml substrate (25
ml citric acid buffer, 25 ml d H20, 5 mg phenylene diamine 0.018 ml 30%
II202) was added at timed intervals. After sufficient color change, the
reaction was stopped with 8N H2SO4. Absorbance was read at 490 nm and
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the lactoferrin concentration of the unknowns determined from the standard
curve.
Lysozyme Assay
Lysozyme hydrolyzes the mucopeptide cell wall structure of the
organism Microc0ccus lysodeikticus. This process is accompanied by loss of
absorbance over tine which is proportional to the lysozyme concentration.
A 0.25 mg/ml suspension of Micrococcus lysodeikticus (Sigma, St. Louis,
MO) was prepared using 0.1M phosphate buffer. 0.1 ml of standard or
neutrophil supernatant sample was added to l ml of the Icrococcu.s
suspension and the loss of O.D. at 450 nm was determined using a
spectrophotometer with kinetics software (Beckman, Brea. CA).
Assay of Microbicidal Activity
Chemotaxis, adherence, the generation of oxygen metabolites, and
degranulation all function to defend the host against invading
microorganisms. FDF have been found to affect many of the above functions
and one could hypothesize that FDF might affect killing as well. To test
vhether FDF affect killing, the S. aureus killing assay was chosen. This assay
has an advantage in that the compound lysostaphin can be used to lyse
extracellular bacteria if needed.
S. aureus was prepared by overnight culture (18 hours) in trypticase soy
broth, washed and adjusted to 5 x 107/ml using a standard curve (CFU vs.
A650). FDF (0.2 ml) at various concentrations 30, 15, 7.5 were added to 0.5
ml of neutrophils for a final FDF concentration of 8.6, 4.3 and 2.15,
respectively. The PMN-FDF mixture was placed in a waterbath for 20
minutes at 37’C. After the incubation, 0.5 ml bacteria at 5 x 107 and 5 x 106
were added to the PMN for l:l and 10:l PMN/bacteria ratios, respectively.
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The PMN-bacteria samples were placed on a rotating tube rack and incubated
for I hour at 37C. Following the incubation, 0.2 ml of each sample vas
added to 1.8 ml of H20 for hypotonic lysis of the neutrophils. Serial dilutions
were carried out and the bacteria were plated out on Muellar-Hinton agar
plates. The plates were counted and CFU determined following a 24 hour
culture.
Separation of FDF by Molecular Weight Using Ultrafiltration
FDF e30,000 daltons were separated according to molecular weight
using Amicon ultrafiltrations (Lexington Mass). 200 ml of FDF 30,000 MW
were run over an Amicon PM-10 membrane (excludes proteins >I0,000
daltons). The retentate, (10,000 30,000 daltons) was resuspended to its
original volume with 0.02 M tris buffer and lyophylized. The filtrate was
them run over a YM-2 and the resulting retentate (100- 10,000 daltons)and
filtrate (1000 daltons) were lyophylized. Before incorporation into the
H202 assay, all fractions were normalized according to peptide concentration
using absorbance at 212 nm.
Antibody Blocking of FDF Suppressive Activity
If the inhibitory activity demonstrated in the previous experiments is
fibrinogen related, then if ep!topes are present antibody should be able to
remove all or part of the inhibitory activity. The following experiments
make use of protein A linked sepharose beads (Sigma) which bind the Fc
portion of IgG thereby forming an insoluble complex.
100 mg of protein A linked seoharose beads were incubated with l ml of
rabbit anti-human fibrinogen serum for l hour. Normal rabbit serum was
used as a control and treated in the same way. Both samples were washed
exhaustively with PBS following the incubation. The sepharose-protein A-IgG
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was centrifuged for 20 minutes at 500 g. The pellets were saved and reacted
with l ml of FDF for l hour. Following the incubation the beads were spun
down and the supernatant (FDF) was saved. These FDF samples were diluted
and used in the H202 assay using opsonized zymosan as a stimulus.
Protease,,.Sensitivity of., FDF Inhibitory Activity
A nonspecific neutral protease was added to the FDF to determine if
the FDF inhibitory activity is protease sensitive. Protease (2 units Pronase
E, Sigma) from Streptomyc,.e..s griseus made insoluble by covalent attachment
to beads was added to I ml FDF 30 OD for 3 hours at 30C (l unit ,ill
hydrolyze 1.0 mole of N c Benzoyl-L Arganine ethyl ester per minute, pH
7.0, 30 C). Following the incubation the beads were removed by
centrifugation (500 x g 8 minutes). Protease treated samples were then
incorporated into the PMN H20 2 assay. To control for nonspecific sticking
of peptides to the beads, and equal volume of Sepharose 4b was added to l ml
FDF removed by centrifugation and the supernatant collected and
incorporated into the H202 assay. The ability of FDF and protease treated
FDF to inhibit stimulated (10-6M f-met-leu-phe) li202 production by PMN
was tested.
Effect of FDF on PMN LFA-I and MO-1 Antigen Levels
PMN (0.5 ml, 1.0xl07/ml) were incubated with buffer o. 0.2 ml FDF for
a final FDF concentration of 8.6, 4.3 and 2.15 as previously described.
Following a 30 minute incubation with the FDF at 37C, the PMN were
placed on ice and brought up to l ml with 0.3 ml of PBS with 0.02% azide for
a final PIN concentration of 5xI06/ml. 0.2 mI of the PMN were added to
0.005 ml mouse anti-human LFA-I (Ortho diagnostics Raritan, NJ)or 0.005
ml of mouse anti-human MO-I (Coulter Immunology Hialeah, FL) and
incubated for 45 minutes on ice. After the incubation period 2.5 ml of PBS
(0.02% azide) were added to each tube and centrifuged 400 g 8 minutes. The
supernatant was decanted and the pellet washed 2 more times with PBS with
azide. After the last wash, 0.005 ml of goat anti-mouse IgG-FITC (Coulter,
Hialeah, FL) was added to each tube and incubated for 30 minutes. The cells
were then washed 3X as above. After the last wash 0.5 ml of 2% buffered
formalin was added to each tube for 30 minutes to fix the cells; followed by
centrifugation. The labelled cells were resuspended in 0.5 ml PBS with azide
and stored in the dark at 4C until analysis.
Analysis was performed at the FACS service (U. Conn. Health Center
Department of Pathology) on a Becton Dickinson FACS analyzer with data
analyzed on a Becton Dickinson consort 30 mini-computer. Cells were grated
on the granulocyte population as observed by viewing volume versus side
scatter.
Stat.istieal Analysis
For each experiment, control cells (buffer treated) were paired with
ex.perimental (FDF treated) c.ells. For this reason, Student’s paired t test was
used to determine whether differences between control and experimental cell
responses were statistically sig.nificant.
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RESULTS
Assessmea.t,.of Fibrinogen purity.
In order to attribute any bioactivity to FDFs, establishing the purity of
the fibrinogen used is clearly important. The use of pure fibrinogen is of
utmost importance to these studies. Previous studies in Dr. Kreutzer’s
laboratory had established the commercially available fibrinogen preparations
contain impurities such as complement and fibroneetin which have biologic
activities. Therefore SDS-PAGE (reduced and non-reduced), as well as
enzyme linked immunoabsorbent assays specific for C3 and C5, were used to
determine fibrinogen purity.
SDS-PAGE Analysis: The fibrinogen preparation was found to
have no impurities such as albumin detectable by SDS-PAGE (see figure 5).
The fibrinogen sample ran as a single band corresponding to a molecular
weight of 340,000.
SDS-PAGE Analysis Reduced SamP!.es: Reduced fibrinogen
samples possessed three bands corresponding to the a, and chains. No
other contaminating bands were evident. Most importantly, the fibrinogen
preparations were found to be free of fibronectin contamination on SDS-
PAGE. Fibronectin when reduced exhibits a band with a molecular weight of
200,000. Bands of MW 200,000 were not detectable in any fibrinogen samples
run.
Complement Componen.t Analysis: C3 and C5 antigen levels were
determined using an ELISA. C3 and C5 antigen levels were determined to be
572 ng/mg fibrinogen and 70 ng/mg fibrinogen respectively. Considerin a
I0% molecular weight conversion of C3 to C3a, or C5 to C5a 57 ng of C3a
and 7 ng of C5a would be present for every m of fibrinogen. This low level
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FIGURE 5
7.5% SDS-PAGE
18 Hour Plasmin Digestion of Fibrinogen
Figure 5: SDS-PAGE pl&smin digestion of fibrinogen
Lane 1: fibrinogen; Lane 2:1 minute plasmin digestion;
Lane 3:15 minutes; Lane 4:1 hour; Lane5:5 hours;
Lane 6:18 hours; Lane 7: molecular weight standards.
of C3 and C5 was found not to have chemotactic activity in our assay and
therefore is unlikely to have significant impact on our in vitro studies.
Pattern of Plasmin Digestion of Fibrinogen
The products generated with the plasmin digestion of fibrinogen are
well known. 18 Generally, the first high molecular weight fibrinogen
fragment to appear is fragment X MW 240,000, followed by fragment Y
145,000, fragment D MW 92,000, and fragment E MW 50,000. The same
pattern of piasmin digestion is seen in figure 5 which is a 7.5% SDS-PAGE gel
of aliquots removed during FDF preparation. At l minute, fragments X, Y,
and D have appeared. At l hour fragment X is beginning to disappear and the
band corresponding to fragment E is starting to appear. At 5 hours fragments
X and Y are gone and there is a dark band corresponding to fragment E. At
18 hours of digestion only evidence of fragments D and E are visualized (see
Figure 5, lane 6). Therefore. Figure 5 demonstrates that the starting
fibrinogen preparation is pure (within the resolution limits of SDS PAGE) and
that the proteolysis pattern follows a pattern which has been previously
described in the literature. 20
Effect of FDF on PMN Viability
To evaluate the effect of FDF on PMN viability, the LDH assay
chosen. FDF were added to neutrophil preparations at the biologically
relevant concentrations used in all assays. For example 0.2 ml of a 30 OD
unit FDF preparation contains 260 lg of protein and corresponds to a starting
fibrinogen concentration of 6 mg/ml. The assay for LDH measures LDH
leakage from PMN cytoplasm and is designed so that the concentration of
LDH is the rate limiting step. Therefore, the rate of reaction for the
conversion of NADH to NAD is directly proportional to the LD.H
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concentration in the FDF exposed PMN supernatant. 80 As can be seen from
Table l, the background LDH release from control PMNs (b,ffer treated) is
much less than the total amount of LDH present in the cells (Triton-treated
lysed cells). Using 3 different FDF preparations the amount of LDH released
from the PMN treated with FDF is not statistically different from those
treated with buffer. Therefore, it does not appear that FDF affect PMN
viability or cause cell injury at biologically relevant concentrations when
using LDH-release as a marker of cell viability.
Effect Of FDF on PMN, Morphology
Since FDF had effect on PMN viability experiments were carried out to
investigate the effect on FDF on PMN morphology. A difference between
the morphology of FDF treated cells and buffer treated cells may provide
insights related to effects of FDF on neutrophil function. Morphological
differences were observed between FDF treated and buffer treated (control)
PMN. When FDF treated PMN were placed on plastic, they appeared round
and failed to spread. Control PMN (buffer treated) were uniformly spread on
the plastic culture dishes (see Figure 6).
When suspensions of FDF treated and control PMN were evaluated using
electron microscopy, control cells appeared to have a granular surface with
short ridges (Figure 7a and 7b). FDF treated cells appeared less granular
with extended ridges (see Figure 7c and 7d). The increased length of FDF
treated PMN cellular ridges or processes is confirmed using transmission
electron microscopy. FDF treated PMN (Figure 9) appear to have longer and
more numerous cytoplasmic processes than buffer treated cells (Figure 8).
Interestingly, cytopathologic changes e.g. (vacuolization) are absent from
both FDF and buffer treated cells.
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FIGURE 6
Effect of FDF on Human Neutrophil Adherence to Plastic
To determine the effect of FDF on neutrophil adherence to plastic
0.05 M1 5 X106 PMN/ml were exposed to 0.2 ml of FDF (30 OD) or
buffer (37 C, 20 minutes) followed by incubation on culture
plastic for 30 minutes. Experimental cells appear round and
have not spread (Figure 6B) Control cells have spread (Figure
6A). Magnification 400x.
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FIGURE 6
A. Buffer treated (control) PMN on plastic.
B. FDF treated PMN on plastic.
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FIGURE 7
Scanning Electron )dicroscopy Evaluation of the Effects of FDF on
Human Neutrophil Morphology
To determine the effect of FDF on neutrophil morphology 0.5 ml
of PMN 1 x 107 PMN/ml were exposed to FDF (30 OD) or buffer
(control) for 20 minutes at 37C. Both experimental and control
cells were submitted in suspension for scanning electron
microscopy. Cells were placed on micropore filters (10,000x).
Control and experimental cells have different morphological
appearances. Control cells appear to have granular surfaces with
slight ridges (Figure 7A and 7B). FDF treated cells appear less
granular with extended ridges (Figure 7C and 7D). In a double
blind study using 50 random photo micrographs, 2 independent
investigators were able to distinguish control cells from FDF
treated cells 79% and 72% respectively.
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FIGURE 8
Ultrastructural Analysis of Buffer Treated(Control) Human
PMN by Transmission Electron Microscopy
To control for nonspecific in vitro effects on neutrophil
ultr.astructure human PMN were exposed to buffer (HBSS) for
20 minutes at 37 C. Following this incubation, the cells were
submitted in suspension for evaluation by transmission
electron microscopy (magnification 8000x). No significant
ultrastructural changes are evident in the photomicrograph.
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FIGURE 9
Ultrastructural Analysis of the Effect of FDF on Human PMN
PMN (0.5 ml of 1 x 107 PMN/ml) were incubated with 0.2 ml
FDF 30 OD (for a final concentration of 8.60D) and incubated
for ’20 minutes. Following the incubation, PMN were
ubmitted for transmission electron microscopy. When
mpared to control (buffer treated) PMN, no cytopathologic
anges were evident. Additionally, TEM analysis supported
SEM studies (Figure 7) which suggested that surface
-ations are induced by FDF.
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Effect of FDF on Cbemotaxis
Chemotaxis is the directed movement of cells along a chemotactic
gradient and results in the recruitment of cells to a site of inflammation.
The regulation or control of chemotaxis functions to: l) maintain cells at the
site of inflammation, 2) limit tissue injury by limiting cell movement into a
tissue site where healing is occurring.
In this present study FDF were found to inhibit chemotaxis in a dose
dependent manner. As can be seen from Figure 10, inhibition was significant
at the 8.60D units (-52%), 4.3 OD units (-42%) and the 2.15 OD units (-37%)
FDF concentrations. Washing of the cells resulted in removal of almost all of
the inhibitory activity for the 8.6 (-5%) and 4.3 (-3%) doses, and all of the
acivity for the 2.15 FDF dose. Addition of FDF to the upper compartment of
the Boyden chamber resulted in significant inhibition of random migration as
well, for PMN not exposed to chemotactic factors. The chemotactic index
for FDF treated PMN was 696 _+ 113, versus a control chemotactic index of
If21 _+272, p0.05. Additionally, the FDF were not found to be chemotactic
at the concentrations used, i.e. FDF chemotactic index at a concentration of
8.60D = If21 _+ 133 as compared to a control chemotactic index I061.25
89.61, p>0.05. To control for the non specific effect of small peptides on
neutrophil function, an 18 hour digest of commercially available bovine serum
albumin was prepared. Due to the presence of significant amounts of
contaninating gamma globulin in the BSA preparation, peptides from this
protein were also produced. Methods used for production of the BSA peptides
were identical to those used for FDF p,oduction. BSA/gamma albumin
peptides 30,000 daltons (30 OD) were incubated with the PMN for 20
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Figure 10" Effect of FDF on PMaN Chemotaxis.
To determine the effects of FDF on neutrophil chemotaxis,
FDF were incubated with 2.5 x 106 cells/ml, for 20 minutes
at 37 C and incorporated into a standard multiwell Boyden
chamber assay. Buffer treated PMN were used as controls.
Positive wash samples were washed twice following FDF
treatment and were incorporated into the assay. Mean
chemotactic indices were calculated from 4 experiments and
percent inhibition of chemotaxis expressed as (experimental
chemotactic index/control chemotactic index) -1 x 100%.
Significant (p<.05) inhibition of chemotaxis was observed for
2.15, 4.30 and 8.60 dose levels. The FDF inhibition was
significantly reversed by washing of the FDF exposed PMN
prior to addition to the Boyden Chamber Assay.
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minutes followed by incorporation into the chemotaxis assay. The addition of
BSA/gamma globulin peptides to this assay did not result in inhibition of
chemotaxis, but actually caused a small, but statistically insignificant,
increase in chemotaxis. The mean chemotactic index for buffer treated cells
was 1912 + 182 as opposed to a chemotactic index for BSA treated PMN of
2147 +158.
Effect of FDF on SRBC- PMN Adherence
Adherence of a particle, or microbe to the neutrophil membrane often
is receptor mediated and is one of the first steps involved in phagocytosis.
The effect of FDF on antibody coated SRBC-PMN adherence was measured
to probe for possible effects of FDF on membrane receptors.
Figure II shows the immune adherence index plotted versus FDF
concentration. As can be seen from the graph, FDF significantly decreased
the adherence of antibody coated sheep RBC to human PMN. A significant
dose response was not seen in this assay. This may be due to the large
standard error and the choice of index. To rule out any effect the FDF may
have on the RBC, FDF (30 O D) were added to the SRBC followed by washing.
Addition of FDF to the RBC had no effect on PMN-RBC adherence when
compared to non FDF treated PMN-RBC reactions (data not shown).
ffect of,, FDF on, PMN Phagoeytosis
Phagocytosis is an important function involved with PMN microbicidal
activity and wound healing. Any effect of FDF on phagocytosis would be
important in regulating a variety of responses that occur as a result of this
function, e.g. cell activation, degran,Hation.
When the FDF were added to the PMN samples, phagocytosis was
significantly inhibited (Figure I2). Inhibition is significant and increased up
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Figure 11" Effect of FDF on PMN-SRBC Adherence.
p<.05
To determine the effects of FDF on PMN-SRBC
adherence, FDF were incubated with a final
concentration of 2.5 x 106 PMN/ml. for 20 minutes
at 37C. Antibody coated sheep red blood cells
were added to the PMN (PMN:RBC 1"1) and
adherence was quantified microscopically.
Adherence Index Number of PMN >1 adherent
’RBC/200 PMN. Sample duplicate smears were
prepared and 3 fields per slide counted. Values
represent the means of 3 experiments. Significant
inhibition of SRBC adherence was observed for the
2.15, 4.30 and 8.60 dose levels (p<.05).
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Figure 12" Effect of FDF on Phagocytosis of
Opsonized RBC by PMN.
To determine the effect of FDF on PMN
phagocytosis, various concentrations of FDF were
incubated with the PMNs for a final concentration
of 2.5 x 10(i PMN as previously described.
Opsonized RBC were added to the PMN at a 1"10
PMN:RBC ratio followed by lysis of adherent
extracellular RBC by ammonium chloride. PMN
were cytocentrifuged and sample duplicate smears
prepared. Phagocytosis was quantified
microscopically counting 3 fields of 200 PMN.
Phagocytic index Number of PMN >_.1 intracellular
RBC/200 PMN. Values represent the means of 4
experiments. FDF significantly inhibited
phagocytosis at all FDF doses(p<.05).
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to the FDF concentration of 4.3, resulting in approximately 50% inhibition of
phagocytosis. At the 8.6 FDF concentration there is a slight increase in
phagocytosis, however, it is still significantly less than the control samples.
As with the adherence assay, FDF (30 OD) were added to the RBC first,
followed by washing to rule out any direct effect of FDF on the RBC. There
was no difference between RBC treated with FDF followed by washing, and
controls in the phagocytosis assay.
Effect of FDF on PMN Chemiluminescence
PMN chemilumescence is an excellent indicator of PMN oxidative
metabolism and has been be used as a general indicator of cell activation. 78
To determine the effect of FDF on cell activation and PMN oxidative
metabolism, PMN resting and stimulated chemiluminescence was measured.
Resting Chemiluminescence is significantly inhibited for all
concentrations of FDF used (Table 2). FDF does not activate PMN and
appears to be suppressing the oxidative metabolism of the resting ceil.
Stimulated Chemiluminescence was inhibited for all doses tested (Table
2). Statistical significance was achieved at the 8.6 and 2.15 FDF dose level.
Effect of FDF on PMN H20__2 Production
Stan.dar.d Curve for. H202production
Previous reports by Pick et a156 have shown that the change in
absorbance that accompanies the oxidation of phenol-red is linear and an
accurate indication of H202 concentrations from 0-80 pM of H202. To
determine H202 concentrations in our assay, and test the direct effect of
FDF on our assay system, a standard curve for H202 levels was established.
The standard curve (Figure 13) demonstrates that a relatively linear
relationship .can be obtained between absorbance at 610 nM and H202
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TABLE 2
EFFECT OF FDF ON RESTING AND STIMULATED HUMAN PMN CHEMILUMINESCENCE
PERCENT INHIBITION1
FDF CONCENTRATION
8.6 absorbance unit
4.3 abosrbance units
2. 15 absorbance units
RESTING PMN
-35.25+2.45
p<.05
-38.25+_1.94
p<.05
-28.5+_4.8
p<.05
n=4
sTIMUC’TED PMN2
-31.85+/-3.84
p<.05
-28.6+/-6.08
p>.05
.20.83-1-4.78
p<.05
n=6
1. percent inhibition (Experimental CPM/Control CPM) -1 x 100%.
2. PMN stimulated with opsonized zymosan.
3. FDF concentration expressed as absorbance units at 212 nm.
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Figure 13" H202 Standard Curve Using Phenol Red
Assay.
H202 concentration was determined by usin,,e,
H202 nolar extinction coefficient of 81 moles/cn.
at 230 nm. A linear dose response (Abs. vs. H202)
was seen between 0 and 50 micromoles/ml.
concentration. FDFs were added to the standard curve samples and they did
not interfere with the assay.
St!mu,!a,,ted P,./IN. H202 Production
H202 is an important chemical species involved in PMN microbicidal
activity. It is required for the functioning of the myeloperoxidase-halide
system which is thought to be of primary importance in PMN microbicidal
activity. For this reason the effect of FDF on PMN H202 production was
tested.
Figure 14 shows the ability of FDF to affect H202 release by 3
different stimuli. FDF significantly inhibit H202 release in a dose dependent
fashion for all three stimuli. FMLP stimulated H202 production is more
susceptible to low concentrations of FDF than PMA or zymosan. This effect
may be due to the strength of the stimulus involved. Interestingly, FDFs
inhibit H202 release by FMLP and PMA. These stimuli are not dependent on
Fc receptor function or phagocytosis, but are dependent upon cytoskeletal
organization. Incubation of PMN with peptides derived from an 18 hour
plasmin digestion of BSA/gamma globulin failed to inhibit H202 production
by PMN. H202 release from buffer treated cells was 52 m/ml as opposed
to 57 pm/ml for BSA treated PMN.
Effect of FDF on Degranulation
Degranulation is dependent upon stimulus-response coupling at the PMN
membrane. Therefore the effect of FDF on zymosan stimulated
degranulation was studied. Certain granule constituents may be used as
markers: lactoferrin is a secondary granule marker, and 8 glucuroni.dase is a
primary granule marker. However, lysozyme is found in both primary and
secondary granules.
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Figure 14" The Effect of FDF on Stimulated H202
Release by PMN.
The ability of FDF to affect H202 release
by 3 different stimuli (10-6M FMLP, 10-7M
PMA and 10’1 opsonizecl zymosan) was
assayed using the phenol red assay for H202.
Values represent the means of 5
experiments. FDF were incubated with a
final PMN concentration of 1 x 107 PMN/ml.
Significant inhibition of H202 release was
seen for all 3 stimuli except for PMA and
zyymosan at the 2.30 dose level.
FDFs significantly inhibited lactoferrin release from PMN at the 8.6
and 2.15 dose levels (Fgure 15). The values represent the means for three
independent experiments. Inhibition of lactoferrin release occurred at the
4.3 dose level, however, it was not statistically significant. FDF statistically
increased 3 glucuronidase release for all three dose levels (Figure 16).
Interestingly, FDF had no statistically significant effect on lysozyme release
(Figure 17).
Effect of FDF on,PMN Micr,obicidal A,,e,tivity
Adherence, phagocytosis, cell activation and H202 production are all
important functions involved in PMN microbicidal activity. 37 Therefore one
would predict that the FDF that affect these functions would affect PMN
microbicidal activity as well. Thus the ability of FDF to inhibit PMN
microbicidal activity was investigated.
Figures 18 and 19 show that FDFs significantly inhibit PMN killing of S.
aureus at both I:l and 10:i PMN/Bacteria ratios. As reflected by an increase
in S. aur.eus viability, statistical significance was achieved at the 8.6 FDF
concentration for the 10:i PMN/Bacteria samples (figure 18). It would
appear that at lower dilutions, inhibition can be partially overcome if the
PMN greatly outnumber the bacteria present. At the l:l PMN/Bacteria
ratios (figure 19) significance is achieved at the 8.6 and 4.3 concentrations,
but not at the lowest dilution. This is in keeping with the dose response
relationships seen for the peptides; at lower dilutions the inhibitory effect is
of smaller magnitude and statistical significance is lost.
Antibody Blocking of FDF Suppressive Aqtivity
To verify the fibrinogen derived nature, of the FDF activity, antibody
blocking studies were undertaken. Ths, the removal of FDF inhibitory
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Figure 15" The Effect of FDF on Lactoferrin Release
from Human PMN Granules.
To determine the effect of FDF on secondary
granule release, lactoferrin (a secondary granule
marker) was quantified in phagocytic supernatants
from control(buffer) and FDF treated PMNs. For
these studies, various concentrations of FDF were
incubated with 1 x 107 PMN as previously
described followed by stimulation with opsonized
zymosan (10"1 zymosan’PMN). Buffer treated
(HBSS) samples served as controls. Lactoferrin
release was quantified by ELISA using a monoclonal
Ab. FDF significantly inhibited phagocytosis
stimulated lactoferrin release by PMN at the 8.60
and 2.15 dose levels. Lactoferrin release at the
4.30 dose level was inhibited, however statistical
significance was not achieved.
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Figure 16" The Effect of FDF on Glucuronidase
Release from Human PMN
*p<.05
To determine the effect of FDF on primary
granule release, g glucuronidase (a marker for
primary granules) was quantified. FDF were
incubated with 1 x 107 PMN/ml.. as previously
described in the methods section. 13 glucuronidase
release was stimulated with opsonized zymosan
(10"1 zymosan’PMN). Supernatants from 3
different neutrophil samples were analyzed for
glucuronidase release. Values represent the means
of 3 experiments. FDF significantly increased
enzyme release at all dose levels (p<.05).
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Figure 17" The Effect of FDF on Lysozyme Release
from Human PMN Granules
The effect of FDF on phagocytosis induced
release of lysozyme, a marker of primary and
secondary granules, was determined using the
general protocol outlined in the methods section.
FDF were incubated with a final concentration of 1 x
10 7 PMN and lysozyme release was stimulated with
opsonized zymosan 10"1. Lysozyme release was
quantified from 3 different PMN supernatants by
measuring the lysis of Micrococcus lysodeikticus.
FDF had no significant effect on lysozyme release
(p>.05).
65
20
I.- 16
14
’12-
X ’10
4
2
PMN:BACTERIA 10"1
/,
::::;:";";::’.;::::"
BUFFER 2.1 5 4.3 8.6
FDF CONCENTRATION (A.212)
Figure 18" Effect of FDF on Killing of S.aureus by
PMN .at a 10"1 PMN" Bacteria ratio.
To determine the effect of FDF on PNEN
nicrobicidal activity, FDF were incubated with PMN
at 5 x 107 PMN/ml for 20 minutes. Following this
incubation 5 x 106 S....aure.us were added to the PMN
to a final 10"1 PMN’Bacteria ratio and incubated.
The PMN .S, aureus mixture was subjected to
hypotonic lysis and plated on Meullar-Hinton agar.
S. aureu.s viability is expressed as CFU x 104
surviving per sample. Values equal the means of 6
experiments. FDF significantly inhibited PMN
killing of S... aur.eus at the 8.60 dose level (p<.05).
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Figure 19" Effect of FDF on Killing of .S. aureus by
PMN at a 1"1 PMN’Bacteria ratio.
To determine the effect of FDF on PMN
microbicidal activity, FDF were incubated with a
final PMN concentration of 5 x 107 PMN/ml as
previously described. Following the incubation 5 x
10 7 S. aureus bacteria were added to the PMN to a
final PMN/Bacteria ratio of 1:1. PMN were
subjected to hypotonic lysis followed by plating on
Muellar-Hinton agar. .S..aureu.s viability is
expressed as CFU surviving per sample. The data
presented represents the means of 7 independent
experiments. FDF significantly suppressed PMN
killing of S. aureus at the 4.30 and 8.60 dose levels
(p<.05).
activity by fibrinogen specif}c antibody would lend support to the claim that
the inhibitory activity seen is fibrinogen derived.
In a series of 3 experiments, antibody absorbed or NIS treated FDF
were added to PMN in the H202 assay using opsonized zymosan as a stimulus.
As can be seen in Figure 20, cells exposed to the antibody absorbed samples
released significantly more H202 at the 8.6 and 4.3 dose levels. Controls
demonstrated that resting cells were not activated by the Ab absorbed FDFs,
thus they contained no inherent stimulatory activity (data not shown). .ny
effect of antibody or serum contamination can be ruled out in that the
normal rabbit serum absorbed FDF samples are not different from those
exposed to FDF alone.
Separation of FDF. Activity by M.olec.ul.ar Weight
To develop a preliminary characterization of FDFs responsible for
suppression of PMN production, FDF were separated according to molecular
weight using Amicon ultrafiltration (see Figure 21). Two distinct molecular
weight ranges of activity were seen. FDFI000 daltons and 10,000- 30,000
d.altons significantly suppressed PMN H202 production. No significant
activity was seen for the 1,000-10,000 dalton fraction. Thus these data
suggest a heterogeneous distribution of at least l FDF activity i.e. PMN
H202 suppression.
E.ffeet of .Pronase-E.on FDF Inhibit0.A..etivity
To determine whether FDF activity was protease sensitive, a broad
spectrum protease was used (see table 3 for peptide bond susceptibility).
Figure 22 represents the effect of the neutral proteaseo Pronase E, on FDF
inhibitory activity. Non protease treated FDF significantly inhibited FMLP
stimulated H202 production by PMN. However, there was no significant
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Figure 20" Effect of Anti-Fibrinogen Antibody on
FDF Inhibitory Activity
The ability of specific antibody to remove FDF
activity was tested using anti-fibrinogen antibody.
Rabbit anti-human fibrinogen antibody was
incubated with protein-A-sepharose
(Normal rabbit serum was used as a
sepharose protein-A-anti-fibrinogen
FDF followed by centrifugation and
antibody. FDF, anti-fibrinogen treated FDF,
treated FDF, were tested for their ability to
for 1 hour.
control.) The
was added to
removal of
PMN H202 production in
Anti-fibrinogen antibody
inhibitory activity at the
There was no significant
and NRS treated
production.
and NRS
inhibit
the phenol red H202 assay.
significantly removed FDF
4.30 and 8.60 dose levels.
difference between FDF
FDF in their inhibition of PMN I-t202
Ab.fibrinogen
NRS
*p<.05
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Fractionation of FDF Inhibitory (H202
by Ultrafiltration.
To further characterize
< 30,000 daltons were
weight fractions using
fraction was normalized
concentration and assay
PMN H202 production.
of 4 experiments Two
ranges of activity were
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specific effects of small fibrinogen peptides
FDF inhibitory activity FDF
separated into 3 molecular
amicon ultrafiltration. Each
with respect to protein
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Values represent the means
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on PMN.
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Figure 22" Effect of Pronase-E on the PMN-H202
Inhibitory Activity of FDF.
The protease sensitivity of FDF inhibitory
activity for PMN production of H202 was tested
using a non-specific protease from Strept0myces
gris.eus covalently linked to sepharose beads. FDF
were incubated with 2 units of bead immobilized
pronase-E, or control beads for 3 hours. The
protease immobilized or control beads were
removed from the sample by centrifugation. The
resulting supernatants were tested for PMN
inhibitory activity using the phenol red H202
Values represent the means of 3 experiments.
There were no significant differences between
protease treated FDF and control samples (beads
alone) in their ability to inhibit H202 production by
PMN.
assay.
difference between the samples treated with protease linked to beads, and
those treated with beads alone p>0.05 in their ability to inhibit H202
production. There were differences between the protease control samples,
protease samples, and the FDF treated samples in their inhibition of H202
production at the 2.15 and 8.6 dose levels. These differences are not believed
to be due to protease activity, since there are no differences between the
samples treated with protease linked to beads and beads alone, but due to non
specific absorption of FDF to the beads thus non-specifically removing FDF
activity.
Effect of,FDF ,on LFA-! and M..O-I An.tigen Levels_ on PMN
Data developed by this project suggested the possibility that part of the
FDF activity may involve adhesion molecules. Thus, the effect of FDF on
two adhesion molecules on the surface of human PMN was evaluated, i.e.
LFA-I and MO-I. As can be seen from Figure 23, FDF significantly increase
the amount LFA-I antigen on the surface of PMN at the 2.15 dose level
(p<0.05). Doses 4.3 and 8.6 increased the level, however, the increase was
not statistically significant. Interestingly, FDF had no significant effect on
"r/Io-I antigen levels (Figure 24). Thus these data raise the possibility that
the FDF induced alterations of adhesion molecules on the surface of the PMN
may be responible for the suppressive activity of the F DF on human
neutrophils.
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Figure 23" Effect of FDF on MN LFA-] Antigen
Expression.
*p<.05
The ability of FDF to alter adhesion molecule
expression on the surface of PMN was studied using,
a monoclonal Ab. to LFA-1. 5 xl06 PMN/ml were
incubated with FDF for 20 minutes and then placed
on ice. PMN were labelled with mouse anti-human
LFA-1 followed by washing and labelling with a
secondary antibody conjugated to FITC. Cells were
fixed and submitted for FACS analysis. Values
represent the average of mean fluorescent values
for 4 experiments. FDF significantly increased the
mean fluorescence(and LFA-1 antigen levels) on
PMN at the 2.15 FDF dose level (p<.05).
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Figure 24" Effect of FDF on PMN MO-1 Antigen
The ability of FDF to affect cell adhesion
molecules on the surface of PMN was studied usino
a monoclonal antibody to MO-1. 5 x 106 PMN/ml
were incubated with FDF for 20 minutes and then
placed on ice. PMN were labelled with mouse anti-
human MOol followed by washing and labelling
with a secondary antibody conjugated to FITC. Cells
were fixed and submitted for FACS analysis. Values
represent the mean fluorescent values for 3
experiments. FDF had no significant effect on MO-1
antigen levels.
DISCUSSION
Fibrin is found in many inflammatory disease processes and is known to
be rapidly metabolized by a variety of enzymes, including plasmin, which
produce a wide range of degradation products locally at the site of
inflammation. These degradation products have been shown to possess a
variety of effects in vitro_ and in vivo. FDFs have been shown to affect
coagulation,5 vasopermeability,22 endothelial cell integrity,64,65
inflammatory cell chemotaxis, 21 angiogenesis, 33 lymphocyte function20 and
delayed-type hypersensitivity reactions61 in vivo. However, to date, no
systematic studies have been undertaken to investigate the effect of FDFs on
neutrophil function in vitro or in vivo. This is surprising in light of the fact
that: l) neutrophils are present in virtually all lesions in which fibrin(ogen) is
found, 2) the neutrophil is thought to be an important component of host
defense.
In its role in host defense, the neutrophil is a highly specialized cell
with its primary function being the destruction of microorganisms and the
preparation of tissue for healing.38 The neutrophil response to microbial
invasion can be divided into a number of stages including l) A.dherence to
vascular endothelium followed by chemotaxis which recruits nflammatory
cells to the site of microbial invasion. 2) Binding and Phagocytosis: the
microorganism binds to the neutrophil membrane which invagnates
internalizing the microorganism in a phagocytic vacuole, 3 Killing of the
Microorganism: which is accompanied by a metabolic burst in which reactive
oxygen metabolites are produced, fusing of enzyme containing granules with
the phagolysosome, and release of granule components extracellularly. ..hus
factors which would modulate any or all of these events i.n host defense could
have a marked impact on microbial invas,on and tissue injury.
This thesis is the result of my preliminary studies (see Appendix
experiments l and 2) which demonstrated the ability of FDF to inhibit PMN
microbicidal activity The results of the present studies have not only
supported the ability of FDF to suppress microbicidal activity i_.n vitro., but
have demonstrated the ability of FDF to inhibit a number of neutrophil
functions important in host defense (see Table 4). Since many of the
functions studied are adhesion dependent, the observed FDF inhibitions of
neutrophil function may involve alterations in neutrophil adherence.
Recently investigators have begun to recognize the importance of adhesion
molecules on the surface of the PMN. I It has been hypothesized that cell
surface adhesion molecules represent a group of surface receptors such as the
fibronectin receptor, platelet fibrinogen receptor, leukocyte adhesion
molecules (LFA-I, MO-l), thought to belong to a family of wide ranging
molecules linked with the cytoskeleton34. In this capacity they function in
wide ranging control of cell functions such as migration in embryos, 33 wound
healing,33 phagocytosis34 and T lymphocyte help34 to name lust a few.
Small molecular weight peptides produced by enzymatic activity (FDFs) may
bind to these cell surface molecules inhibiting cell movement during
embryogenesis and chemotaxis, thus providing fine tuned local regulation of
these processes.
How would FDFs function in inflammation and what role do bacteria
play in this process? My working hypothesis is that low molecular weight
FDFs produced late in an inflammatory lesion function to down regulate
(inhibit) the immune response limiting local tissue damage. However,
bacterial proteases may take advantage of this process, producing FDF which
allow for increased bacterial growth and tissue damage. Therefore, FDFs
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may play a role in many disease processes where bacteria are present and
local regulation of disease activity is occurring (e.g. inflammatory
periodontal disease).
In order to study the effect of FDF on host defense, the effect of FDF
on each stage involved in PMN function was examined. As mentioned earlier
these steps include adherence, chemotaxis, phagocytosis, degranulation and
oxygen metabolism. In the present studies, FDF were found to inhibit all of
these steps as well as produce recognizable morphologic changes and up
regulate cell surface adhesive molecules (see Table IV). Provided below is a
detailed discussion related to those experimental findings and their
implications for the regulation of neutrophil function !n vitro and host
defense in vivo.
Fibrinogen Purity and. the.....Use of..Biologically Relevant Concentrations
Previous studies which have investigated the effects of FDF on
lymphocyte function have not addressed the question of fibrinogen purity
prior to enzymatic digestion. Fibrinogen preparations may contain impurities
capable of stimulating (e.g. complement) or inhibiting (e.g. fibronectin) cell
function. In this study considerable effort was made to purify the fibrinogen
prior to digestion. Complement contamination was sufficiently low so that it
was unlikely to be of biological significance in these reactions.43 Since
fibronectin was not evident on SDS PAGE, it appears that the starting protein
was highly purified fibrinogen.
The concentration of fibrinogen or FDF used in in vitro experiments
must be consistent with that found in vivo for the experiments to have
biologic relevance. The highest concentration of peptides used in the various
experiments presented (30 absorbance units) corresponded to a starting
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TABLE 4
SUMMARY OF EFFECT OF FDF ON NEUTROPHIL FUNCTIONS
FUNCTION EFFECT
VIABILITY
CHEMOTAXIS
PHAGOCYTOSIS
CHEMILUMXNESCENCE
H202 RELEASE
LACTOFERRIN RELEASE
13 GLUCURONIDASE RELEASE
LYSOZYME REIEASE
MICROBICIDAL ACTIVITY
MO- 1 ANTIGEN
LFA-1 ANTIGEN
fibrinogen concentration of 6 mg/ml. Fibrinogen is present in plasma at a
concentration of 3-4 mg/ml.19 Moreover, fibrinogen, as an acute phase
reactant, can reach concentrations as high as 30-40 mg/mll9 during acute
inflammation. The deposition of large amounts of fibrin in both acute and
chronic inflammatory lesions may lead to even higher local concentrations of
FDF. Therefore the concentration of FDF used in the experiments described
is within the range seen in
.viv9 and in fact much higher levels may be seen in
Effect of FDF on Chemotaxis
One of the first steps in the inflammatory process is the movement of
PMN from the vascular bed to a site of injury or bacterial invasion. Once the
cells arrive at the site of inflammation, mechanisms must exist to limit their
further movement out of the area. Moreover, mechanisms must exist to
reduce or prevent chemotaxis of additional cells into a lesion once healing
has been initiated, preventing further tissue damage by PMN proteases.
FDFs may play a role in these immunoregulatory pathways.
Experiments presented in this thesis have shown that FDFs can inhibit
PMN chemotaxis as well as random migration. This inhibition was found to
be reversible upon washing, and specific since peptides derived from BSA
degradation had no effect on chemotaxis. The finding that the inhibitory
effects of FDF are reversible supports their role as possible
immunoregulators. Permanent down regulation of PMN by a factor (FDF) in
an inflammatory lesion may not be desirable.
Present experiments have not found these small peptides (FDF) to be
chemotactic. It must be noted, however, that other studies have found
fibrinogen peptides to be chemotactic. IIoweve’, these studies employed
either thrombin derived peptides36, or found major chemotactic activity of
molecular weight >_.30,000 daltons.47 In addition, no study to date has
investigated the effect that preincubation of PMN with FDF have on PMN
chemotaxis as this study has done.
In support of experimental findings related to chemotaxis presented
here, recent experiments by other investigators in our laboratory have
demonstrated the ability of FDF peptides, identical to that used in these
experiments, to inhibit endothelial cell migration.33 Therefore, there is
evidence that FDFs affect chemotaxis of other cell types as well.
In light of these data it is hypothesized that that FDFs may bind to the
neutrophil membrane mimicking matrix proteins such as fibronectin and
fibrinogen. The FDFs may function to saturate membrane bound adhesive
molecules reducing cell adhesiveness and motility.
Effect of FDF on SRB.CT.P..MN...Ad.h.erence and...P.hagocytosis
The first step in phagocytosis is the binding of a particle to the
neutrophil membrane and FDFs were found in this study to significantly
inhibit binding of antibody coated SRBC to P.N membranes. A clear dose
response was not seen in the adherence assay. However, this may be due to
the high standard error present and the selection of the index used for
measurement of adherence. Counting all cells with l adherent RBC tended
to obscure the finding that with increasing FDF concentration there were less
cells with 2 or 3 adherent RBC (see Appendix). Inhibition of binding can
affect all subsequent steps in killing and it cannot be said whether the
inhibition of phagocytosis seen is due to a direct effect on phagocytosis or
due to decreased binding, floweret, inhibition of phagocytosis was significant
at all dose levels in the erythrophagocytosis assay.
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A possible mechanism to explain the effects of FDF on SRBC adherence
and phagocytosis might include binding of FDF to the Fc receptor and other
cell surface adhesion receptors. For example, nhibition of platelet receptor
binding to fibrinogen by small peptides has been described58 and this receptor
has been found on P MNs.8 It is possible that FDF bind the Fc receptor of
PMN down regulating adherence and subsequent phagocytosis of antibody
coated cells. Any effect of the FDF on the RBC is less likely due to
experiments that incubated the FDF with the RBC followed by washing and
incorporation into the assay. FDF treated RBC had no effect on adherence
or phagocytosis. Thus these studies suggest that FDF inhibition of SRBC-
PMN adherence and phagocytosis is due to a direct effect on the PMN.
Effect of FDF on Chemiluminescence and H20__2 Production
It is well established that binding of an opsonized particle or a
chemotactic peptide to a PMI’I results in a metabolic burst in which light
(chemiluminescence) and several reactive oxygen metabolites (tt202)
produced.78 Because of the role of these oxygen metabolites in host defense
the effect of FDF on II20 2 and chemiluminescence was studied.
It is noteworthy that FDF had effects on the resting cell, inhibiting
resting chemiluminescence. This s an effect, that is independent of the
binding of a chemotactic factor or opsonized particle to the cell. It appears
the resting cell is down regulated by FDF.
FDFs have been shown to inhibit IgG mediated RBC adherence and
phagocytosis to the PYIN membrane. Addition of the FDF to the SRBC had
no effect. Therefore, evidence exists for FDF affecting binding of opsonized
particles to the P},N membrane. This fact may, in part, explain the effect of
FDF on stimulated chemiluminescence. Part of the effect seen may be due
to the inhibition of binding of opsonized zymosan by the FDF resulting in
decreased stimuli. }{owever, the suppressive ei’fects of FDF may be a result
of other effects on PMN metabolism as suggested from the resting
chemiluminescence data.
Chemiluminescence is an excellent indicator of PMN oxidati.ve
metabolism.78 Therefore the finding that FDF inhibit both stimulated
chemiluminescence and H202 production is not surprising. The finding that
FDF inhibit H202 production from 3 seemingly unrelated stimuli supported
the general suppressive effect of the FDF. The general suppressive effect on
H202 production may be due to FDF affecting a common cellular pathway, or
due to a number of peptides affecting individual pathways. Another possible
mechanism to account for these data might include FDF binding to cell
surface receptors. This binding could prevent the interaction of serum
opsonins (e.g. C3b on zymosan) and chemotactic factors with their individual
receptors; inhibiting the stimuls for .H202 production. The peptide sequence
x-Arg-GIy-Asp-y, found to inhibit cell adhesion to fibrinogen and
fi.bronectin, 16 is found in the fibrinogen molecule and the complement
component C3.16 Moreover, it has been found to bind to a number of cell
surface receptors. 34 It is possible that FDF with sequences related to x-Arg-
Gly-Asp-y, or other peptides bind to the C3b or f-met-leu-phe receptor
inhibiting binding and H202 production. Some degree of specificity was
demostrated in present experiments when peptides derived from BSA were
shown not to inhibit H202 production. The effect of FDF with PMA
activation is [note complex since PMA is thought to have multiple effects in
addition to activating protein kinase .52 Protein kinase C is involved with
the phosphorylation of proteins resulting in the control of calcium fluxes and
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receptor transport. PMA, in its activation of protein kinase C, has been
thought to be an agonist.52 However, protein kinase C can be involved with
7eceptor down regulation and a report describes the PMA inhibition of
neutrophil response to chemotactic peptides.50 FDF by binding to the
neutrophil membrane may act to affect PMA transport into the cell or may
function to decouple the activation of protein kinase C from cell activation.
Ef.f.ect 0f FDF on PMN .Degranulation
A critical aspect of the phagocytic process is the incorporation of
agents toxic to microorganisms into the phagocytic vacuole. Following
binding and phagocytosis, PMN cytoplasmic granules (separated into two
distinctive populations, primary and secondary) move and fuse with the
phagocytic vacuole releasing various proteolytic enzymes. Moreover, the
contents of the granules can often be released extracellularly due to
incomplete closure of the phagocytic vacuole, or ruture of the cell causing
death of extracellular microorganisms or host tissue damage. The control of
PMN degranulation is not well understood, however, different granule
populations (primary and secondary) are believed to be responsive to
independent stimuli and secondary granules are involved in receptor transport
to the cell surface (e.g. FMLP). Secondary granule release can be elicited
with stimuli such as PMA and Con A while primary granule release cannot76.
Release of primary granules requires a greater stimulus than secondary
granules76. In addition, secondary granules are thought to be more readily
released into the extracellular environment; primary granules tend to fuse
with the phagolysosom e76.
Since prilnary and secondary granules may require different stinuli for
release, it is not surprising that FDF have the opposite effects on their
release. FDF suppress secondary granule release and potentiate primary
granule release. The effect of FDF on neutrophil granule release may affect
the character of PMN mediated connective tissue destruction. For example,
an increase in primary granule release would cause an increase in the release
of enzymes such as elastase which can degrade connective tissue
proteoglycans24. Inhibition of secondary granule release could function to
prevent the release of an important anti-microbial agent (lactoferrin)as well
as inhibit the transfer of f-met-leu-phe receptors to the cell surface.
Whether FDF affect signal response coupling, cytoskeletal events or some
other cellular process has not been elucidated. However, the effect of
peptides found in inflammatory lesions could alter the course and outcome of
disease processes in vivo.
Effect of. FD.F on PMN Mic..robicidal Activity
The primary function of phagocytosis degranulation and the generation
of oxygen metabolites is to defend the host against invading microorganisms.
Since FDF have been shown in this thesis to inhibit many of the functions
involved in PMN microbicidal activity, it is not surprising that microbicidal
activity was suppressed. Present studies demonstrated that FDF inhibition of
killing was dose dependent, statistically significant, and became more
pronounced with the l:i PMN/Bacteria ratio. PMN to bacteria ratios of l:l
and 10:I were chosen because at these ratios PMN killing has been shown to
be the most efficient.38 Experimental conditions in which bacteria greatly
outnumber PMN (e.g. bacterial plaque in the gingival sulcus) might introduce
other variables such as bacterial toxins etc. which might cause neutrophil
death.
Effect of FDF on LFA-I and MO-I Antigen Levels
Many of the functions that FDF have been shown to affect are
dependent on adhesion of microorganisms to the cell surface. In keeping with
the hypothesis that FDF affect cell surface adhesion molecules, experiments
were performed to examine the effect of FDF on the cell adhesion molecules
LFA-I and MO-I. Evidence is accumulating that these molecules are
important in neutrophil function and host defenseI. Present experiments
have demonstrated the ability of FDF to significantly increase the amount of
LFA-I antigen on the surface of PMN. FDF had no significant effect on MO-
l antigen levels. The greatest effect on LFA-I antigen levels occurred at the
lowest FDF concentration. These data suggest that FDF may be binding to
cell surface adhesion receptors stimulating an increase in cell surface
receptors in a manner analogous to the binding of a chemotactic factor such
as f-met-leu-phe. For example, when a PMN binds to a venuole in vivo, up
regulation of adhesive receptors may occur. However, if FDF are present
(the inflammatory lesion is resolving), FDF binding to adhesive receptors
might block margination and diapedesis.
I_dentity of Active FDFs
The identity and relative homogeneity of FDF(s) which down regulate
neutrophil function has not been demonstrated. In fact, it is clear that the
FDF preparations contain a variety of peptides. Thus some peptides may be
stimulatory and others may be inhibitory. Clearly, in vitro and in vivo, the
relative concentration for the PMN of each of the peptides vould determine
the ultimate regulation of PMN function.
Data obtained from separation of FDF according to molecular ,eight
shows two molecular weight ranges of activity: FDFI000 d and
10,000FDF30,000 d. The finding that FDF I,000 daltons have activity is
in good agreement with other studies showing that peptides of molecular
weight in the range of 500 daltons are able to bind to cell surface receptors
and inhibit cell function.67 The total lack of activity seen in the 1,000-
I0,000 molecular weight range would argue against any non specific effects
of small peptides on the cells. Present experiments performed to investigate
the susceptibility of FDF to a non specific protease have not demonstrated
protease sensitivity. This may be due to a lack of peptide bond susceptibility
in the peptide(s) that accont for FDF activity. Finally, antibody blocking
experiments support the fibrinogen related identity of the FDF activity
response for suppressing PMN-H202 production i_n vitro. Data presented here
strongly suggests that the PMN inhibitory activity demonstrated is fibrinogen
related and that significant activity is found MWI,000. These data suggest
that small molecular weight peptides of fibrinogen can inhibit PMN function
i_.n v.i.tro and may regulate PMN function in vivo. The exact identity of these
peptides remains to be determined.
Conclusion
The ability of FDF to inhibit functions related to host defense may have
important immunoregulatory and immunopathologic consequences. FDF
inhibition of chemotaxis may inhibit the host’s initial response to microbial
invasion. Increased fibrinolytic activity found surrounding tumors may inhibit
recruitment of PMN to the tumor site, and subsequent killing of tumor cells.
Moreover, work done by other investigators in Dr. Kreutzer’s lab, using
peptides identical to those used in present experiments, has demonstrated the
ability of FDF to inhibit endothelial cell migration. Therefore, FDF may
affect other diverse cellular kinetic processes such as angiogenesis and
neovascularizations and embryogenesis.
FDF inhibition of phagocytosis and killing of microorganisms may
affect the course and severity of diseases of microbial etiology. Bacterial
virulence factors in combination with FDF may act to favor bacterial
proliferation over host defenses. Phagocytosis is important in wound healing.
Therefore, FDF may inhibit the ability of the host to repair damage once it
has occurred.
The finding that FDF preferentially stinulate primary granules and
inhibit secondary granule release may affect PMN extracellular release of
proteases into host tissues in vivo. The increase in release of primary granule
contitutents such as elastase may cause increased connective tissue
destruction.
Currently, the mechanism(s) of action of FDF is unknown but we have
developed preliminary data to suggest that one possible mechanism for FDF
induced suppression of PMN function may involve adhesion dependent
functions. The ability of small molecular weight peptides derived from
fibrinogen degradation to up-regulate the cell adhesive protein LFA-I is
interesting in light of recent work done with fibronectin. The peptide x-Arg-
Gly-Asp-y which represents the putative cell binding site of fibronectin, has
been found to bind to a number of cell surface receptors inhibiting cellular
function.67 The sequence x-Arg-Gly-Asp-y has been shown to: inhibit
adhesion, spreading, and microfilament organization on fibrinogen coated
surfaces 16 inhibit experimental mettasis f murine melanoma cells 32
block neural crest cell migration33 and bind to the platelet fibrinogen
receptor lib-Ilia inhibiting platelet interactions with that molecule. 58
The platelet fibrinogen receptor has been identified on PMN8 and is
believed to function in adhesion. Moreover, the platelet fibrinogen receptor
lib-Ilia is thought to belong to a family of cell surface adhesion receptors
(LFA-I, MO-I) involved in cell locomotion and phagocytosis34. Therefore, an
adhesive molecule has been described on PMN which binds fibrinogen and
whose function is blocked by small peptides derived from a matrix protein.
Experimental evidence pertaining to the Arg-Gly-Asp peptide is
particularly relevant because: l) the sequence is found twice in the c chain
of fibrinogen, 2) the sequence Arg-Gly-Asp is found in the complement
component C3, I6 3) small peptides related to fibrinogen and fibronectin are
able to bind to cell surface receptors inhibiting function in many cells. 67 It
is possible that small peptides (FDF) regulate cell function by occupying
tissue matrix binding sites and opsonin receptors on PMN during the
inflammatory processes. This process would provide an opportunity for local
control of an inflammatory lesion and provide a mechanism by ,hich
pathogens could take advantage of local regulatory processes to promote
their proliferation and tissue invasion.
Thus data obtained from this study provide a variety of interesting
avenues of investigation. For example, the identification of specific peptides
which inhibit cell function and the receptors involved will provide new
insights into the regulation of local and systemic immune function. In
addition, the identification of specific factors that inhibit cell migration etc.
may provide exciting therapeutic possibilities. These agents may be used
therapeutically to control the repopulation of wounds by specific cell types
and affect wound healing (e.g. periodontal attachment procedures).
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Moreover, development of inhibitors of cell movement may prevent and
thereby limit PMN-mediated tissue damage (e.g. rheumatoid arthritis).
Finally, the characterization of the biologic significance of specific
FDF will be instrumental in diagnosis and treatment of inflammatory diseases
such as periodontal disease.
Therefore, in the future, investigation into the role of these peptides in
biologic systems will provide the clinician as well as the basic scientist with
new and exciting areas of research.
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